Abstract 2883: Dectin-2 agonist antibodies reprogram tumor-associated macrophages to drive anti-tumor immunity by Kenkel, Justin A., Ho, Po Y., Henning, Karla A., Kreder, Cindy L., Nolin, Jess L., Kongara, Sameera, Chapin, Steven J., Husain, Amreen, Kowanetz, Marcin, Engleman, Edgar G., Alonso, Michael N., Dornan, David, Ackerman, Shelley E.

Get full text

Abstract 2964: Targeting tumor-associated macrophages to enhance anti-tumor immunity with the Dectin-2 agonistic antibody BDC-3042 by Kenkel, Justin A., Xiao, Fang, Ho, Po Y., Nolin, Jess L., Gadkari, Rishali K., Torrez, Laughing Bear, Omstead, David T., McEachin, Katelynn A., Ptacek, Jason, Grgich, Rachel, Pearson, Cecelia I., Chun, Stefan, Kreder, Cindy L., Henning, Karla A., Kim, Han K., Xu, Lu, Chapin, Steven J., Alonso, Michael N., Ackerman, Shelley E.

Get full text

Abstract 2911: The CEA-targeted ISAC, BDC-2034, shows preclinical efficacy associated with innate immune activation, phagocytosis, and myeloid reprogramming by Blum, Lisa K., Pearson, Cecelia I., Dulgeroff, Laughing Bear Torrez, Gadkari, Rishali, Luo, Angela, Luo, Andrew, Melrose, Jennifer E., Nolin, Jess L., Li, Hai, Lee, Arthur, Zhou, Matthew N., Anand, Puneet, Sarma, Ganapathy, Henning, Karla A., Chapin, Steven J., Ackerman, Shelley E., Kudirka, Romas, Shen, Yuyi, Hug, Bruce, Perez, Edith A., Kowanetz, Marcin, Alonso, Michael N., Safina, Brian S., Dornan, David, Mallet, William G.

Get full text